levodopa has been researched along with Autonomic Failure, Progressive in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abele, M; Albanese, A; Barone, P; Berciano, J; Boesch, S; Bozi, M; Cardozo, A; Coelho, M; Colosimo, C; Daniels, C; Del Sorbo, F; Deuschl, G; Djaldetti, R; Dupont, E; Fowler, C; Galitzky, M; Gasser, T; Geser, F; Giladi, N; Gonzalez-Mandly, A; Gurevich, T; Kamm, C; Klockgether, T; Köllensperger, M; Mathias, CJ; Meco, G; Ndayisaba, JP; Nilsson, CF; Oertel, W; Ostergaard, K; Pellecchia, MT; Poewe, W; Quinn, N; Rascol, O; Sampaio, C; Schimke, N; Schrag, A; Seppi, K; Siebert, U; Tison, F; Tolosa, E; Wenning, GK; Widner, H; Yekhlef, F | 1 |
| Albanese, A; Bellacchio, E; Dallapiccola, B; Elia, AE; Romito, LM; Valente, EM | 1 |
| Gross, G; Krause, KH; Nagel-Hiemke, M | 1 |
| Cartlidge, NE; Gibson, GJ; Gilmartin, JJ; Wright, AJ | 1 |
| Tippett, GO | 1 |
| Idiáquez, J | 1 |
| Bergmans, PL; Konings, CH; Kuiper, MA; Wolters, EC | 1 |
| Cannon, RO; Eisenhofer, G; Goldstein, DS; Holmes, C; Kopin, IJ | 1 |
| Egi, N; Harada, T; Kumagai, R; Kurokawa, K; Nakamura, S; Okazaki, M; Shimote, K | 1 |
| Mueller, J; Poewe, W; Puschban, Z; Scherfler, C; Seppi, K; Stefanova, N; Wenning, GK | 1 |
| Mathias, CJ | 1 |
| Masson, C | 1 |
| Calne, DB; Cooper, S; Cordes, M; Morrison, S; Schofield, P; Snow, BJ; Sossi, V; Takahashi, H | 1 |
| Lindvall, B; Olsson, JE | 1 |
| Ahlskog, JE; Fealey, RD; Low, PA; Sandroni, P | 1 |
| Gubskiĭ, LV | 1 |
| Kondo, T; Nagatsu, T; Narabayashi, H; Yokochi, F | 1 |
| Gaio, JM; Hommel, M; Mallaret, M; Perret, J; Pollak, P | 1 |
| Rae-Grant, A; Spence, JD; Young, GB | 1 |
2 review(s) available for levodopa and Autonomic Failure, Progressive
| Article | Year |
|---|---|
Neurodegeneration, parkinsonian syndromes and autonomic failure.
Topics: Autonomic Nervous System Diseases; Brain; Cardiovascular Physiological Phenomena; Diagnosis, Differential; Humans; Levodopa; Multiple System Atrophy; Parkinsonian Disorders; Shy-Drager Syndrome; Sympathetic Nervous System | 2002 |
[Dysautonomia and multi-systemic atrophy of the nervous system (Shy-Drager's syndrome)].
Topics: Aged; Anus Diseases; Autonomic Nervous System Diseases; Eye Diseases; Female; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease; Shy-Drager Syndrome; Time Factors; Urinary Bladder Diseases; Vasoconstrictor Agents | 1992 |
1 trial(s) available for levodopa and Autonomic Failure, Progressive
| Article | Year |
|---|---|
Blood pressure effects of apomorphine and domperidone in parkinsonism.
Topics: Adult; Aged; Aged, 80 and over; Apomorphine; Blood Pressure; Clinical Trials as Topic; Domperidone; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Shy-Drager Syndrome | 1987 |
16 other study(ies) available for levodopa and Autonomic Failure, Progressive
| Article | Year |
|---|---|
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
Topics: Age of Onset; Antiparkinson Agents; Cerebellar Ataxia; Europe; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Registries; Shy-Drager Syndrome | 2010 |
The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease.
Topics: Age of Onset; Brain; Diagnosis, Differential; Dopamine Agents; Energy Metabolism; Genetic Predisposition to Disease; Humans; Italy; Levodopa; Male; Middle Aged; Mitochondria; Mitochondrial Diseases; Mutation; Parkinson Disease; Parkinsonian Disorders; Phenotype; Protein Kinases; Shy-Drager Syndrome; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2005 |
Plasma catecholamines during activation of the sympathetic nervous system in a patient with Shy-Drager syndrome.
Topics: Autonomic Nervous System Diseases; Benserazide; Catecholamines; Dopamine; Epinephrine; Female; Humans; Levodopa; Middle Aged; Norepinephrine; Physical Exertion; Posture; Shy-Drager Syndrome; Sympathetic Nervous System | 1980 |
Upper airway obstruction complicating the Shy-Drager syndrome.
Topics: Adult; Airway Obstruction; Autonomic Nervous System Diseases; Benserazide; Double-Blind Method; Humans; Levodopa; Male; Shy-Drager Syndrome; Tidal Volume | 1984 |
Levodopa: long-term impact on Parkinson's disease.
Topics: Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Humans; Levodopa; Parkinson Disease; Shy-Drager Syndrome | 1981 |
[Idiopathic orthostatic hypotension (Shy Drager's syndrome) (author's transl)].
Topics: Autonomic Nervous System Diseases; Female; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Shy-Drager Syndrome | 1980 |
Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients.
Topics: Aged; Aged, 80 and over; Atrophy; Basal Ganglia Diseases; Blood Platelets; Brain; Dopamine; Enzyme Induction; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Olivopontocerebellar Atrophies; Parkinson Disease; Shy-Drager Syndrome | 1993 |
Sympathetic cardioneuropathy in dysautonomias.
Topics: Adult; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Diagnosis, Differential; Dopamine; Fluorine Radioisotopes; Heart; Humans; Levodopa; Middle Aged; Myocardium; Norepinephrine; Parasympathetic Nervous System; Parkinson Disease; Reference Values; Shy-Drager Syndrome; Sympathetic Nervous System; Tomography, Emission-Computed | 1997 |
[A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Fludrocortisone; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Shy-Drager Syndrome | 1998 |
Overstimulation of the alpha1B-adrenergic receptor causes a "seizure plus" syndrome.
Topics: Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Brain; Cerebral Cortex; Disease Models, Animal; Dopamine Agents; Epilepsy, Tonic-Clonic; Humans; Inclusion Bodies; Levodopa; Mice; Nerve Tissue Proteins; Neurodegenerative Diseases; Parkinsonian Disorders; Prazosin; Receptors, Adrenergic, alpha-1; Shy-Drager Syndrome; Syndrome; Synucleins; Tyrosine 3-Monooxygenase | 2001 |
[L-18F-dopa-PET in Parkinson-plus syndromes for the detection of a disordered presynaptic dopaminergic function].
Topics: Aged; Dopamine; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
Topics: Dystonia Musculorum Deformans; Enkephalin, Methionine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Shy-Drager Syndrome; Somatostatin | 1990 |
Autonomic involvement in extrapyramidal and cerebellar disorders.
Topics: Adult; Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Cerebellar Diseases; Cognition Disorders; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reflex; Shy-Drager Syndrome; Supranuclear Palsy, Progressive; Valsalva Maneuver | 1991 |
[Diagnosis and treatment of Shy-Drager syndrome].
Topics: Autonomic Nervous System Diseases; Diagnosis, Differential; Drug Therapy, Combination; Ephedrine; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Mineralocorticoids; Movement Disorders; Shy-Drager Syndrome | 1989 |
Clinical effects of L-threo-3,4-dihydroxyphenylserine in cases of parkinsonism and pure akinesia.
Topics: Adult; Aged; Antiparkinson Agents; Droxidopa; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Parkinson Disease, Secondary; Serine; Shy-Drager Syndrome | 1987 |
Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndrome.
Topics: Autonomic Nervous System Diseases; Carbidopa; Drug Combinations; Female; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Monoamine Oxidase Inhibitors; Shy-Drager Syndrome | 1985 |